Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Advances in Experimental Medicine and Biology is Scopus-indexed (Q1, CiteScore 3.4). Published by Springer.
Checked against the index lists dated .
ISSN 0065-2598Verify ISSN ↗2214-8019Verify ISSN ↗
Publisher: Springer
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (all) | 166 / 669 | 75th | Q1 |
| Biochemistry, Genetics and Molecular Biology (all) | 108 / 223 | 51st | Q2 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1971–present, best quartile Q1, CiteScore 3.4.
Advances in Experimental Medicine and Biology is Q1 in Medicine (all) (rank 166 of 669) and Q2 in Biochemistry, Genetics and Molecular Biology (all) (rank 108 of 223), by CiteScore 2025.
Advances in Experimental Medicine and Biology is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 3.4, quartile Q1, 75th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.485, quartile Q3, with an H-index of 180.
Advances in Experimental Medicine and Biology is published by Springer. Its print ISSN is 0065-2598 and its online ISSN is 2214-8019.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Advances in Experimental Medicine and Biology has an h-index of 220 and a 2-year mean of 2.32 citations per paper (OpenAlex). Its Scopus CiteScore is 3.4, quartile Q1. On 2-year citations it ranks #121 of 646 Scopus journals in Medicine (all).
Advances in Experimental Medicine and Biology published 662 papers in 2025; its busiest recent year was 2019 with 1,514. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 36 research articles (2021–2025), authors are most often from Iran (26.2%), Poland (20.1%) and United Kingdom (13.2%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 12 retracted papers are recorded (0.3 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.